EX-99.2 3 exhibit_99-2.htm EXHIBIT 99.2


Exhibit 99.2
 
Financial Information for the Three Months and Six Months Ended June 30, 2023 and 2022 of Kenon and OPC and
 
Reconciliation of Certain non-IFRS Financial Information

Table of Contents

Appendix A: Summary of Kenon’s consolidated financial information

Appendix B: Summary of OPC’s consolidated financial information

Appendix C: Definition of OPC’s Adjusted EBITDA and non-IFRS reconciliation

Appendix D: Summary of financial information of OPC’s subsidiaries

Appendix E: Definition of ZIM’s Adjusted EBITDA and non-IFRS reconciliation


Appendix A

Summary Kenon consolidated financial information

Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Financial Position (Unaudited)

   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
$ millions
 
Current assets
           
Cash and cash equivalents
   
590
     
535
 
Short-term deposits and restricted cash
   
16
     
46
 
Trade receivables
   
75
     
74
 
Short-term derivative instruments
   
4
     
3
 
Other investments
   
263
     
345
 
Other current assets
   
50
     
59
 
Total current assets
   
998
     
1,062
 
Non-current assets
               
Investment in ZIM (associated company)
   
226
     
427
 
Investment in OPC’s associated companies
   
675
     
652
 
Long-term restricted cash
   
16
     
15
 
Long-term derivative instruments
   
17
     
16
 
Deferred taxes, net
   
6
     
6
 
Property, plant and equipment, net
   
1,652
     
1,223
 
Intangible assets, net
   
288
     
221
 
Long-term prepaid expenses and other non-current assets
   
81
     
51
 
Right-of-use assets, net
   
132
     
99
 
Total non-current assets
   
3,093
     
2,710
 
Total assets
   
4,091
     
3,772
 
Current liabilities
               
Current maturities of loans from banks and others
   
89
     
39
 
Trade and other payables
   
222
     
134
 
Short-term derivative instruments
   
1
     
1
 
Current tax liabilities
   
-
     
1
 
Deferred taxes
   
-
     
1
 
Current maturities of lease liabilities
   
17
     
17
 
Total current liabilities
   
329
     
193
 
Non-current liabilities
               
Long-term loans from banks and others
   
799
     
610
 
Debentures
   
469
     
513
 
Deferred taxes, net
   
129
     
98
 
Other non-current liabilities
   
39
     
42
 
Long-term lease liabilities
   
57
     
20
 
Total non-current liabilities
   
1,493
     
1,283
 
Total liabilities
   
1,822
     
1,476
 
Equity
               
Share capital
   
50
     
50
 
Translation reserve
   
(5
)
   
1
 
Capital reserve
   
72
     
42
 
Accumulated profit
   
1,303
     
1,505
 
Equity attributable to owners of the Company
   
1,420
     
1,598
 
Non-controlling interests
   
849
     
698
 
Total equity
   
2,269
     
2,296
 
Total liabilities and equity
   
4,091
     
3,772
 

 
2

Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Profit or Loss (Unaudited)
 
   
For the six months
ended June 30,
   
For the three months
ended June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
$ millions
   
$ millions
 
Revenue
   
312
     
267
     
165
     
121
 
Cost of sales and services (excluding depreciation and amortization)
   
(232
)
   
(197
)
   
(129
)
   
(100
)
Depreciation and amortization
   
(30
)
   
(26
)
   
(17
)
   
(13
)
Gross profit
   
50
     
44
     
19
     
8
 
Selling, general and administrative expenses
   
(47
)
   
(44
)
   
(23
)
   
(23
)
Other (expenses)/income
   
(1
)
   
1
     
(2
)
   
-
 
Operating profit/(loss)
   
2
     
1
     
(6
)
   
(15
)
Financing expenses
   
(32
)
   
(27
)
   
(18
)
   
(14
)
Financing income
   
24
     
31
     
11
     
24
 
Financing (expenses)/income, net
   
(8
)
   
4
     
(7
)
   
10
 
(Losses)/gains related to ZIM
   
(1
)
   
202
     
-
     
(2
)
Share in (losses)/profit of associated companies, net
                               
-          ZIM
   
(43
)
   
706
     
(31
)
   
276
 
-          OPC’s associated companies
   
28
     
20
     
4
     
(10
)
(Loss)/profit before income taxes
   
(22
)
   
933
     
(40
)
   
259
 
Income tax (expense)/benefit
   
(10
)
   
(19
)
   
3
     
(2
)
(Loss)/profit for the period
   
(32
)
   
914
     
(37
)
   
257
 
Attributable to:
                               
Kenon’s shareholders
   
(37
)
   
904
     
(30
)
   
265
 
Non-controlling interests
   
5
     
10
     
(7
)
   
(8
)
(Loss)/profit for the period
   
(32
)
   
914
     
(37
)
   
257
 
                                 
Basic/diluted (loss)/profit per share attributable to Kenon’s shareholders (in dollars):
                               
Basic/diluted (loss)/profit per share
   
(0.70
)
   
16.78
     
(0.56
)
   
4.92
 
 
3

Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Cash Flows (Unaudited)

   
For the six months
ended June 30,
 
   
2023
   
2022
 
   
$ millions
 
Cash flows from operating activities
           
(Loss)/profit for the period
   
(32
)
   
914
 
Adjustments:
               
Depreciation and amortization
   
38
     
29
 
Financing expenses/(income), net
   
8
     
(4
)
Losses/(gains) related to ZIM
   
1
     
(202
)
Share in losses/(profit) of associated companies, net
   
15
     
(726
)
Share-based payments
   
5
     
5
 
Income tax expense
   
10
     
19
 
     
45
     
35
 
Change in trade and other receivables
   
4
     
(9
)
Change in trade and other payables
   
(11
)
   
(11
)
Cash generated from operating activities
   
38
     
15
 
Income taxes paid, net
   
(1
)
   
-
 
Dividends received from associated companies
   
152
     
545
 
Net cash provided by operating activities
   
189
     
560
 

4

 
Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Cash Flows (Unaudited), continued

   
For the six months
ended June 30,
 
   
2023
   
2022
 
   
$ millions
 
Cash flows from investing activities
           
Short-term deposits and restricted cash, net
   
30
     
(10
)
Short-term collaterals deposits, net
   
20
     
-
 
Investment in long-term deposits, net
   
-
     
12
 
Investment in associated companies, less cash acquired
   
(2
)
   
-
 
Acquisition of subsidiary, less cash acquired
   
(250
)
   
-
 
Acquisition of associated company, less cash acquired
   
-
     
(1
)
Acquisition of property, plant and equipment
   
(139
)
   
(163
)
Acquisition of intangible assets
   
(5
)
   
(2
)
Proceeds from sale of interest in ZIM
   
-
     
464
 
Proceeds from distribution from associated company
   
2
     
3
 
Proceeds from sale of other investments
   
139
     
248
 
Purchase of other investments
   
(50
)
   
(601
)
Long-term advance deposits and prepaid expenses
   
(7
)
   
(4
)
Long-term loans to an associate
   
(24
)
   
-
 
Interest received
   
12
     
1
 
Proceeds from transactions in derivatives, net
   
2
     
-
 
Net cash used in investing activities
   
(272
)
   
(53
)
                 
Cash flows from financing activities
               
Repayment of long-term loans, debentures and lease liabilities
   
(124
)
   
(20
)
Proceed from Veridis transaction
   
129
     
-
 
Investments of holders of non-controlling interests in the capital of a subsidiary
   
54
     
12
 
Receipt from long-term loans
   
267
     
84
 
Proceeds from/(payment) in respect of derivative financial instruments, net
   
1
     
(1
)
Repurchase of shares
   
(14
)
   
-
 
Costs paid in advance in respect of taking out of loans
   
(5
)
   
(2
)
Dividends paid
   
(150
)
   
(189
)
Interest paid
   
(16
)
   
(13
)
Net cash provided by/(used in) financing activities
   
142
     
(129
)
                 
Increase in cash and cash equivalents
   
59
     
378
 
Cash and cash equivalents at beginning of the year
   
535
     
475
 
Effect of exchange rate fluctuations on balances of cash and cash equivalents
   
(4
)
   
(16
)
Cash and cash equivalents at end of the period
   
590
     
837
 

5

Information regarding reportable segments
 
Information regarding activities of the reportable segments are set forth in the following table.
 
 
 
For the six months ended June 30, 2023
 
   
OPC Israel
   
CPV Group
   
ZIM
   
Other
   
Consolidated Results
 

  $ millions  
Revenue
   
278
     
34
     
-
     
-
     
312
 
Depreciation and amortization
   
(31
)
   
(7
)
   
-
     
-
     
(38
)
Financing income
   
8
     
3
     
-
     
13
     
24
 
Financing expenses
   
(25
)
   
(6
)
   
-
     
(1
)
   
(32
)
Loss related to ZIM
   
(1
)    
-
     
-
     
(1
)
   
-
 
Share in profit/(loss) of associated companies
   
-
     
28
     
(43
)
   
-
     
(15
)
Profit/(loss) before taxes
   
8
     
7
     
(44
)
   
7
     
(22
)
Income tax expense
   
-
     
(3
)
   
-
     
(7
)
   
(10
)
Profit/(loss) for the period
   
8
     
4
     
(44
)
   
-
     
(32
)

 
 
For the six months ended June 30, 2022
 
   
OPC Israel
   
CPV Group
   
ZIM
   
Other
   
Consolidated Results
 

 
$ millions
 
Revenue
   
239
     
28
     
-
     
-
     
267
 
Depreciation and amortization
   
(23
)
   
(6
)
   
-
     
-
     
(29
)
Financing income
   
7
     
22
     
-
     
2
     
31
 
Financing expenses
   
(23
)
   
(4
)
   
-
     
-
     
(27
)
Gains related to ZIM
   
-
     
-
     
202
     
-
     
202
 
Share in profit of associated companies
   
-
     
20
     
706
     
-
     
726
 
Profit/(loss) before taxes
   
5
     
25
     
908
     
(5
)
   
933
 
Income tax expense
   
(3
)
   
(5
)
   
-
     
(11
)
   
(19
)
Profit/(loss) for the period
   
2
     
20
     
908
     
(16
)
   
914
 

6

 
 
For the three months ended June 30, 2023
 
   
OPC Israel
   
CPV Group
   
ZIM
   
Other
   
Consolidated Results
 

 
$ millions
 
Revenue
   
147
     
18
     
-
     
-
     
165
 
Depreciation and amortization
   
(19
)
   
(4
)
   
-
     
-
     
(23
)
Financing income
   
2
     
1
     
-
     
8
     
11
 
Financing expenses
   
(15
)
   
(4
)
   
-
     
1
     
(18
)
Share in profit/(loss) of associated companies
   
-
     
4
     
(31
)
   
-
     
(27
)
(Loss)/profit before taxes
   
(6
)
   
(8
)
   
(31
)
   
5
     
(40
)
Income tax benefit
   
2
     
1
     
-
     
-
     
3
 
(Loss)/profit for the period
   
(4
)
   
(7
)
   
(31
)
   
5
     
(37
)

 
 
For the three months ended June 30, 2022
 
   
OPC Israel
   
CPV Group
   
ZIM
   
Other
   
Consolidated Results
 

 
$ millions
 
Revenue
   
105
     
16
     
-
     
-
     
121
 
Depreciation and amortization
   
(12
)
   
(3
)
   
-
     
-
     
(15
)
Financing income
   
4
     
19
     
-
     
1
     
24
 
Financing expenses
   
(12
)
   
(2
)
   
-
     
-
     
(14
)
Loss related to ZIM
   
-
     
-
     
(2
)
   
-
     
(2
)
Share in (losses)/profit of associated companies
   
-
     
(10
)
   
276
     
-
     
266
 
(Loss)/profit before taxes
   
(13
)
   
2
     
274
     
(4
)
   
259
 
Income tax benefit/(expense)
   
2
     
(1
)
   
-
     
(3
)
   
(2
)
(Loss)/profit for the period
   
(11
)
   
1
     
274
     
(7
)
   
257
 
7


Appendix B
 
Summary of OPC consolidated financial information
 
OPC’s Consolidated Statements of Profit or Loss (Unaudited)
 
   
For the six months ended June 30,
   
For the three months ended June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
$ millions
   
$ millions
 
Revenue
   
312
     
267
     
165
     
121
 
Cost of sales (excluding depreciation and amortization)
   
(232
)
   
(197
)
   
(129
)
   
(100
)
Depreciation and amortization
   
(30
)
   
(26
)
   
(17
)
   
(13
)
Gross profit
   
50
     
44
     
19
     
8
 
Selling, general and administrative expenses
   
(42
)
   
(37
)
   
(21
)
   
(19
)
Other (expenses)/income
   
(1
)
   
1
     
-
     
1
 
Operating profit/(loss)
   
7
     
8
     
(2
)
   
(10
)
Financing expenses
   
(31
)
   
(27
)
   
(19
)
   
(14
)
Financing income
   
11
     
29
     
3
     
23
 
Financing (expenses)/income, net
   
(20
)
   
2
     
(16
)
   
9
 
Share in profit/(loss) of associated companies, net
   
28
     
20
     
4
     
(10
)
Profit/(loss) before income taxes
   
15
     
30
     
(14
)
   
(11
)
Income tax (expense)/benefit
   
(3
)
   
(8
)
   
3
     
1
 
Profit/(loss) for the period
   
12
     
22
     
(11
)
   
(10
)
                                 
Attributable to:
                               
Equity holders of the company
   
11
     
20
     
(6
)
   
(4
)
Non-controlling interest
   
1
     
2
     
(5
)
   
(6
)
Profit/(loss) for the period
   
12
     
22
     
(11
)
   
(10
)
 
8

Summary Data from OPC’s Consolidated Statement of Cash Flows (Unaudited)
 
   
For the six months ended June 30,
   
For the three months ended June 30,
 
   
2023
   
2022
   
2023
   
2022
 
   
$ millions
   
$ millions
 
Cash flows provided by operating activities
   
45
     
29
     
17
     
2
 
Cash flows used in investing activities
   
(369
)
   
(164
)
   
(295
)
   
(77
)
Cash flows provided by financing activities
   
307
     
60
     
86
     
22
 
Decrease in cash and cash equivalents
   
(17
)
   
(75
)
   
(192
)
   
(53
)
Cash and cash equivalents at end of the period
   
221
     
145
     
221
     
145
 

Summary Data from OPC’s Consolidated Statement of Financial Position (Unaudited)
 
 
 
As at
 
 
 
June 30, 2023
   
December 31, 2022
 
 
 
$ millions
 
Total financial liabilities1
   
1,356
     
1,163
 
Total monetary assets2
   
253
     
287
 
Investment in associated companies
   
675
     
652
 
Total equity attributable to the owners
   
1,045
     
997
 
Total assets
   
3,235
     
2,709
 
 
1.
Including loans from banks and others and debentures
2.
Including cash and cash equivalents, term deposits and restricted cash
 
9

Appendix C
 
Definition of OPC’s Adjusted EBITDA and non-IFRS reconciliation

This press release, including the financial tables, presents OPC’s Adjusted EBITDA, which is a non-IFRS financial measure.
 
OPC’s EBITDA is defined for each period as net profit/(loss) before depreciation and amortization, financing expenses, net, and income tax expense and Adjusted EBITDA is defined as net profit/(loss) before depreciation and amortization, financing expenses, net, share of depreciation and amortization and financing expenses, net, income tax expense, share of changes in fair value of derivative financial instruments, changes in net expenses, not in the ordinary course of business and/or of a non-recurring nature and other expenses.  EBITDA and Adjusted EBITDA are not recognized under IFRS as a measure of financial performance and should not be considered as a substitute for net profit or loss, cash flow from operations or other measures of operating performance determined in accordance with IFRS. EBITDA and Adjusted EBITDA are not intended to represent funds available for dividends or other discretionary uses because those funds may be required for debt service, capital expenditures, working capital and other commitments and contingencies. There are limitations that impair the use of EBITDA and Adjusted EBITDA as measures of OPC’s profitability since it does not take into consideration certain costs and expenses that result from OPC’s business that could have a significant effect on net profit, such as financial expenses, taxes, and depreciation and amortization.
 
OPC believes that the disclosure of Adjusted EBITDA provides useful information to investors and financial analysts in their review of the company’s, its subsidiaries’, and its associated companies’ operating performance and in the comparison of such operating performance to the operating performance of other companies in the same industry or in other industries that have different capital structures, debt levels and/or income tax rates.
 
Set forth below is a reconciliation of OPC’s net loss to Adjusted EBITDA for the periods presented. Other companies may calculate EBITDA and Adjusted EBITDA differently, and therefore this presentation of EBITDA and Adjusted EBITDA may not be comparable to other similarly titled measures used by other companies.

   
For the three months ended June 30,
 
 
 
2023
   
2022
 
 
 
$ millions
 
Loss for the period
   
(11
)
   
(10
)
Depreciation and amortization
   
23
     
15
 
Financing expenses/(income), net
   
16
     
(9
)
Share of depreciation and amortization and financing expenses, net, included within share of profit/(losses) of associated companies, net
   
20
     
22
 
Income tax benefit
   
(3
)
   
(1
)
EBITDA
   
45
     
17
 
Share of changes in fair value of derivative financial instruments
   
(2
)
   
9
 
Changes in net expenses, not in the ordinary course of business and/or of a non-recurring nature
   
3
     
-
 
Other expenses
   
1
     
-
 
Adjusted EBITDA
   
47
     
26
 

10


Appendix D
 
Summary Financial Information of OPC’s Subsidiaries
 
The tables below set forth debt, cash and cash equivalents, and debt service reserves for OPC’s subsidiaries as of June 30, 2023 and December 31, 2022 (in $ millions):

 As at June 30, 2023
 
OPC Energy
   
OPC-Rotem
   
OPC-Hadera
   
OPC-Tzomet
   
CPV Keenan
   
Others
   
Total
 
 
                                         
Debt (including accrued interest)
   
1
     
-
     
179
     
286
     
81
     
194
     
741
 
Cash and cash equivalents (including restricted cash used for debt service)
   
11
     
8
     
17
     
14
     
1
     
9
     
60
 
Net debt*
   
(10
)
   
(8
)
   
162
     
272
     
80
     
185
     
681
 


 As at December 31, 2022
 
OPC Energy
   
OPC-Rotem
   
OPC-Hadera
   
OPC-Tzomet
   
CPV Keenan
   
Others
   
Total
 
 
                                         
Debt (including accrued interest)
   
527
     
-
     
190
     
237
     
88
     
1
     
1,043
 
Cash and cash equivalents (including restricted cash used for debt service)
   
166
     
7
     
16
     
3
     
1
     
98
     
291
 
Net debt*
   
361
     
(7
)
   
174
     
234
     
87
     
(97
)
   
752
 

*Net debt is defined as debt minus cash and cash equivalents and deposits and restricted cash.

11

Appendix E
 
Definition of ZIM’s Adjusted EBITDA and non-IFRS reconciliation

This press release, including the financial tables, presents ZIM’s Adjusted EBITDA, which is a non-IFRS financial measure.
 
ZIM defines Adjusted EBITDA for each period as net profit/(loss) adjusted to exclude financial expenses/(income), net, income taxes, depreciation and amortization in order to reach EBITDA, and further adjusted to exclude impairments of assets, non-cash charter hire expenses, capital gains/(losses) beyond the ordinary course of business and expenses related to legal contingencies. Adjusted EBITDA is not recognized under IFRS as a measure of financial performance and should not be considered as a substitute for net profit or loss, cash flow from operations or other measures of operating performance determined in accordance with IFRS. Adjusted EBITDA is not intended to represent funds available for dividends or other discretionary uses because those funds may be required for debt service, capital expenditures, working capital and other commitments and contingencies. There are limitations that impair the use of Adjusted EBITDA as a measure of ZIM’s profitability since it does not take into consideration certain costs and expenses that result from ZIM’s business that could have a significant effect on net profit, such as financial expenses, taxes, and depreciation and amortization.
 
ZIM believes that the disclosure of Adjusted EBITDA enables the comparison of operating performance between periods on a consistent basis. This measure should not be considered in isolation, or as a substitute for operating income, any other performance measure, or cash flow data, which were prepared in accordance with IFRS as measures of profitability or liquidity. In addition, non-IFRS financial measures may not be comparable to similarly titled measures reported by other companies, due to differences in the way these measures are calculated.
 
Set forth below is a reconciliation of ZIM’s net (loss)/profit to Adjusted EBITDA for the periods presented.

   
For the three months ended June 30,
 
 
 
2023
   
2022
 
 
 
$ millions
 
(Loss)/profit for the period
   
(213
)
   
1,336
 
Depreciation and amortization
   
422
     
337
 
Financing expenses, net
   
104
     
28
 
Income tax (benefits)/expense
   
(59
)
   
400
 
EBITDA
   
254
     
2,101
 
Capital loss, beyond the ordinary course of business
   
21
     
-
 
Adjusted EBITDA
   
275
     
2,101
 

12